Previous Close | 417.24 |
Open | 422.16 |
Bid | 427.88 x 300 |
Ask | 429.12 x 900 |
Day's Range | 421.76 - 430.88 |
52 Week Range | 398.50 - 583.39 |
Volume | |
Avg. Volume | 550,079 |
Market Cap | 35.095B |
Beta (5Y Monthly) | 1.36 |
PE Ratio (TTM) | 41.33 |
EPS (TTM) | 10.37 |
Earnings Date | Feb 03, 2025 - Feb 07, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 476.76 |
IDEXX's robust strength in the CAG Diagnostics business and strong global performance are highly promising.
WESTBROOK, Maine, November 21, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group ("CAG") Finance, will succeed Mr. McKeon as IDEXX’s Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. Mr. McKeon will serve as EVP and Special Advisor to the C